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Organ transplantation has been the last line of therapy for saving patients experiencing
end-stage organ failure. However, the success of organ transplantation is critically
dependent on the availability of donor organs. There are high expectations for research on
organ regeneration as a solution to the donor shortage issue faced by transplantation
medicine. Thus, generation of human organs from pluripotent stem cells is now one of the
ultimate goals of regenerative medicine. In recent years, several approaches to using
pluripotent stem cells to generate organs of complex structure and function have been
developed. Reproductive biology plays an indispensable role in the development of
innovative organ regeneration researches. In this review, we discuss the potential of the
animal biotechnology aiming at making human organs using pigs as a platform.
 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Regenerative medicine, including cell transplantation
therapy and tissue engineering, offers an effective approach
for developing treatments of intractable diseases. Still, organ
transplantation has been the last line of therapy in saving
patients experiencing end-stage organ failure when other
therapies are not effective. However, the growing shortage of
organ donors throughout theworld is still a major challenge.
One proposed solution for this serious problem is xeno-
transplantation, inwhich organs of genetically modiﬁed pigs
are used for clinical application [1–3]. As pigs share many
anatomic and physiological characteristics with humans,
xenotransplantation has been an important subject of
research in the last decades [1–3]. In addition, an innovative
approach of generating human tissues and organs
from pluripotent stem cells (PSCs) has been extensively
studied [4–8]. However, human organs with complex physi-
ological functions and three-dimensional structures are
extremely difﬁcult to build in an artiﬁcial culturing environ-
ment. Therefore, the use of animal fetuses is a promising
alternative strategy that may circumvent the problems of4.
a).
vier Inc. This is an open acc
56in vitro organ generation by supporting organ development
fromxenogeneicPSCs inanaturalphysiological environment.
Yokoo et al. [9,10] have shown that the mechanisms sup-
porting kidney growth in animal fetuses could be used to
build kidney tissue that originates from human PSCs. They
transplanted human bone marrow–derived mesenchymal
stem cells into kidney anlagens of rat fetuses (E11.5), cultured
the fetuses in vitro for 2 days, and then extracted the pri-
mordial kidney (metanephros). These metanephroi were
grown further either in vitro for 6 days or as transplants into
omental adipose tissue of immunosuppressed adult rats. The
analysis of the developed renal tissue conﬁrmed that exoge-
nous humanmesenchymal stem cellss participated in neph-
rogenesis, suggesting apossibilityof regeneratinghumanized
organs by using primordial animal organs as a scaffold.
Several studies have been conducted with the aim of
producing transplantable organs based on the mechanisms
of organogenesis in heterologous animal species [9–15].
Recently, a new approach using blastocyst complementa-
tion has been developed and attracted considerable
attention (Fig. 1) [16–18]. It is based on generating animal
fetuses deﬁcient in a speciﬁc organ and using the empty
space in the fetal body as a niche for the growth and dif-
ferentiation of allogeneic or xenogeneic PSCs, ultimately to
form a solid organ.ess article under the CC BY-NC-ND license (http://creativecommons.org/
Fig. 1. Schematic presentation of blastocyst complementation: generation of human organs using organogenesis-disabled pigs as a platform. iPS cells, induced
pluripotent stem cells.
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The pancreatic and duodenal homeobox 1 (Pdx1) gene is
known as a master regulator of pancreas formation. Pdx1
knockout (Pdx1/) mice exhibit a phenotype of pancreatic
agenesis. Kobayashi et al. [16] have reported that these
apancreatic mice can support the formation of the pancreas
from rat PSCs.
The apancreatic Pdx1/mice diewithin a few days after
birth. However, injecting induced PSCs (iPSCs) fromhealthy
rats into the Pdx1/mouse blastocysts has been shown to
result in the generation of chimeric mice carrying the
pancreas developed from rat iPSCs. These research ﬁndings
demonstrate the principal possibility of exploiting an
empty developmental niche (organ niche) in the
organogenesis-disabled fetus for organ formation from
xenogeneic PSCs, which can be applied to the generation of
human organs. Using the in vivo environment provided by
the animals relatively physiologically compatible with
humans would be the key to organ regeneration. Thus, this
approach would offer a deﬁnitive solution to the problem
of shortage of transplantable organs. Therefore, we
conducted a basic study aimed at developing a system
for organ regeneration in pigs, which uses blastocyst
complementation [17].3. Producing pigs with an apancreatic phenotype
We generated transgenic (Tg) pigs that express Hairy
enhancer split-1 (Hes1) under the control of the Pdx1 pro-
moter [17]. The Pdx1-Hes1 Tg midgestation fetuses were
conﬁrmed to lack the pancreas, indicating that the animals
exhibited an apancreatic phenotype. Next, we established
primary ﬁbroblast cultures from the Tg fetuses and used
them for somatic cell–based cloning. The cloned fetuses
and offsprings showed the apancreatic phenotype.
For the production of Tg pigs, we used intracytoplasmic
sperm injection–mediated gene transfer [19,20]. In this
method, frozen sperm heads that were thawed and pre-
incubated with the gene construct were microinjected into
oocytes for fertilization; as a result, foreign genes were
incorporated into the genome of the host egg. With pigs, a
system for mass in vitro production of mature eggs with
high developmental ability has been established. The
intracytoplasmic sperm injection–mediated gene transfer
is, therefore, a very effective practically applicable method
for producing Tg fetuses.
Pigs with the apancreatic phenotype can also be
generated bymethods other than Tg approach. Recently, we
have reported, for the ﬁrst time, that genome editing with
zinc-ﬁnger nuclease is effective for gene knockout in
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several types of gene knockout pigs [22]. We constructed
the transcription activator–like effector nuclease targeting
the pig Pdx1 gene, and introduced Pdx1 mRNA into fetal
porcine ﬁbroblasts. When the resulting Pdx1/ cells were
used for somatic cell nuclear transfer to produce a cloned
fetus, the results conﬁrmed the acquisition of the
apancreatic phenotype similar to that of the Pdx1-Hes1 Tg
fetuses [23].
Thus, in case of the pancreas, the “organogenesis-
disabled” phenotype can be induced by the two described
strategies: tissue-speciﬁc and developmental stage–spe-
ciﬁc hyperexpression of speciﬁc genes and knockout of
master regulator genes. Shedding light on the mechanisms
underlying organogenesis would provide better under-
standing if similar strategies can be applied not only to the
pancreas but also to other organs.
4. Establishing a blastocyst complementation system
in pigs
Pigs with the apancreatic phenotype due to Pdx1-Hes1
overexpression or Pdx1 deﬁciency show neonatal lethality,
which precludes the collection of sperm or fertilized eggs in
the adulthood. However, as stated previously, there are
established techniques for somatic cell cloning in pigs, so
embryos can be produced from somatic cells of Pdx1-Hes1
Tg or Pdx/ apancreatic fetuses or newborns. In other
words, once a genetic engineering method for inducing the
apancreatic phenotype is established, it would enable so-
matic cell cloning for asexual mass production of embryos
with the required genetic trait.
We have used functionally normal allogeneic embryonic
cells (donor cells, female) to perform blastocyst comple-
mentation in cloned porcine embryos with the apancreatic
phenotype (host embryos, male) to determine whether the
allogeneic cell–derived pancreas could be formed in the
resulting chimeric fetuses and offsprings. For the donor
cells, we used porcine Tg blastomeres expressing human-
ized Kusabira-Orange (huKO) red ﬂuorescent protein.
The chimeric pigs obtained by blastocyst complemen-
tationwere conﬁrmed to have formed thepancreas from the
donor cells and reported normal growth and stable blood
glucose levelswithin thenormal range. The animals reached
sexual maturity in about 7 to 8 months after birth, which is
consistent with normal sexual development of domestic
pigs. The chimeric pigs also exhibited normal reactivity for
the oral glucose tolerance test performed on 35 days after
birth, indicating that the pancreases generated from allo-
geneic cellswere fully functional. Furthermore, the chimeric
animals also showed normal reproductive functions. The
phenotype of pancreatic agenesis was transmitted to the
progeny and fetuses obtained by crossing chimeric boars
and wild-type sows, demonstrating that germ cells (sperm)
of chimeric pigs were derived from the cloned embryos
carrying the apancreatic trait. Sperm formation exclusively
from male embryonic cells in a male–female chimeric pig
has also been observed in a previous study [24].
One of the resulting chimeric pigs was autopsied
at 12 months of age [17]. All the organs expressed donor
cell–derived huKO ﬂuorescence, and no macroscopicabnormalities were observed. Histologic analysis of the
pancreas, duodenum, and bile ducts did not reveal any
pathologic alterations. Immunostaining for huKO reported
that almost the entire pancreatic tissue consisted of
huKO-expressing donor cells.
Identifying the genes that regulate organogenesis is
essential for expanding the strategy of artiﬁcial organ
regeneration by blastocyst complementation to multiple
organ types. Thus, in mice, it has been reported that Sall1
knockout results in the phenotype of renal agenesis, which
can be repaired by blastocyst complementation [25], sug-
gesting that organogenesis based on the blastocyst
complementation system has a potential to be applied to a
number of target organswhose formation can be controlled
by modifying a single or few regulatory genes. Gene
knockout using genome editing techniques is a promising
approach to perform organogenesis inhibition.
Future research will focus on establishing human iPSCs
of higher pluripotency (naïve type) and securing large
numbers of embryos and fetuses required for blastocyst
complementation and conceptus complementation. As
organogenesis-disabled phenotypes are fatal, it is impos-
sible to obtain fetuses or embryos by breeding these
genetically modiﬁed animals. Considerable funds and ef-
forts would be required to maintain a herd of heterozygous
latent carriers of organogenesis-disabled traits to obtain
homozygous knockout embryos and fetuses. Another op-
tion for mass production of organogenesis-disabled em-
bryos is using somatic cell cloning. In any case, it is
important to develop effective reproductive technologies,
such as IVF, artiﬁcial insemination, somatic cell cloning,
embryo transfer, and embryo cryopreservation.
5. Conceptus complementation
The chimeric boar we have created using blastocyst
complementation produces sperm carrying the Pdx1-Hes1
gene [17]. Crossing this chimeric male with a wild-type fe-
male would, in accordance with Mendel’s law, produce the
next generation of fetuses or newborns with the
pancreatogenesis-disabled phenotype, which prompted
the idea of using the empty developmental niche of
Pdx1-Hes1 Tg fetuses to regenerate the pancreas from
exogenous pluripotent cells. More speciﬁcally, this is
conceptus complementation (Fig. 2), that is, direct manip-
ulation with Pdx1-Hes1 Tg fetuses to ﬁll the empty organ
niche with the heterologous pancreas. When the loss of a
speciﬁc organ is not fatal for the fetus, as is the casewith the
pancreatogenesis-disabled phenotype, direct intervention
(e.g., cell injection) in the fetal development may be effec-
tive in generating the missing organ from exogenous cells.
We have been conducting experiments where we inject
pancreatic progenitor cells into apancreatic fetuses under
ultrasonic guidance and track the subsequent development
of pancreatic tissue (Fig. 3). Fetuses lacking a speciﬁc organ
are regarded as a suitable environment for the develop-
ment of in vitro–generated organ primordia (organoids)
into functional organs (Fig. 2). However, direct intervention
with fetal development is difﬁcult when the absence of
targeted organs causes embryonic lethality, as is the case
with liver or heart agenesis.
Fig. 2. Conceptus complementation using pig fetuses with organogenesis-disabled phenotype. Porcine fetuses with “organ niche,” that is, organogenesis-
disabled phenotype are expected to be useful to grow human organ progenitors or anlagen. iPS cells, induced pluripotent stem cells.
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The results of our research using cloned embryos have
shown that pig embryos with the apancreatic trait can form
the complete pancreas from normal heterologous plurip-
otent cells [17]. It is also highly likely that porcine iPSCs or
embryonic SCs with chimera-forming abilities can be
similarly used for the formation of the nonautologous
pancreas. However, there are multiple challenges in the
production of the human pancreas or pancreatic tissue by
blastocyst complementation. The formation of the rat
pancreas in a Pdx1/ mouse after complementation withFig. 3. Ultrasound-guided cell injection into a porcine fetus with “organ niche.” (A, B
pig fetus through uterine wall. (C) Cell masses (arrowheads) of organ progenitor wer
remaining in the peritoneal cavity after removal of the injection needle.rat iPSCs is conﬁrmed by the ability of rat pluripotent cells
to contribute to embryonic developmental processes in the
mouse, that is, the early developmental mechanisms in
these species are compatible to a degree that surmounts
species-speciﬁc barriers [16]. However, it is currently un-
known how embryonic cells or PSCs of primates, including
humans, would behave in the developmental environment
provided by the blastocyst complementation system based
on pig embryos as a host and whether cross-species chi-
meras could be formed.
The creation of interspeciﬁc chimeric animals has long
been a research target for reproductive biology [26–29]. A
typical example of such a chimera is the “Geep” obtained) Injection needle (arrow) was inserted into the peritoneal cavity of a Day-40
e injected into the peritoneal cavity of the fetus. (D) Transplanted cell masses
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chimeric blastocysts were constructed with sheep and goat
embryonic cells so that the trophectoderm was generated
by homologous cells of the recipient animal was the key to
the success. Goats and sheep have a similar physiology
including comparable uterine and placental structures,
virtually identical gestation periods, and similarly sized
fetuses. The formation of interspeciﬁc and even interge-
neric chimeras [28] between animals with such a degree of
similarity is thought possible through inhibiting in-
compatibilities between the fetus and surrogate mother,
which are manifested at the time of implantation.
On the other hand, multiple questions should be
answered before attempting to generate chimeras between
animal species (e.g., pigs and humans) with distinct dif-
ferences in the mechanisms of embryonic/fetal develop-
ment, size and growth rate of the fetus, timing of
implantation, placental structure, and so forth. Currently,
very little information is available in this regard.
Indisputably, ethical issues are inherent to the idea of
producing the human pancreas from human iPSCs in pig
fetuses. In experiments on creating animals that contain
cells or tissues of human origin (animals containing human
materials), the possibility of forming human germ cells or
brain cells in the body of a pig has often been a focus of
bioethical concern. This problem can possibly be resolved
by controlling the differentiation fate of human cells. Our
research [17,24] has shown that germ cells are not formed
from exogenous cells when a male host embryo is com-
plementedwith female donor cells, suggesting an approach
to control the formation of human germ cells in pigs during
the process of blastocyst complementation with human
PSCs. Recently, Kobayashi et al. [30] have reported an
approach to stimulate differentiation of exogenous cells
only into endodermal organs by blastocyst complementa-
tion. Thus, it has been conﬁrmed that the expression of
Mix-like protein 1 (Mixl1) induces organ formation only in
endodermal systems during blastocyst formation [30].
Strategies for inhibiting differentiation of pluripotent cells
into central nervous system are yet to be developed. Such
targeted organ generation may help solving ethical prob-
lems associatedwith the generation of human germ cells or
brain cells in the bodies of pigs.
These and other important ﬁndings in the area of
xenogeneic chimera formation bring hope that various
problems mentioned previously would be gradually
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